Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy, with high hyperdiploidy [51 -67 chromosomes] and the t(12;21)(p13;q22) [ETV6/RUNX1 fusion] representing the most frequent abnormalities. Although these arise in utero, there is long latency before overt ALL, showing that additional changes are needed. Gene dysregulation through hypermethylation may be such an event; however, this has not previously been investigated in a detailed fashion. We performed genome-wide methylation profiling using bacterial artificial chromosome arrays and promoter-specific analyses of high hyperdiploid and ETV6/RUNX1-positive ALLs. In addition, global gene expression analyses were performed to identify associated expression patterns. Unsupervised cluster and principal component analyses of the chromosome-wide methylome profiles could successfully subgroup the two genetic ALL types. Analysis of all currently known promoter-specific CpG islands demonstrated that several B-cell-and neoplasia-associated genes were hypermethylated and underexpressed, indicating that aberrant methylation plays a significant leukemogenic role. Interestingly, methylation hotspots were associated with chromosome bands predicted to harbor imprinted genes and the tri-/tetrasomic chromosomes in the high hyperdiploid ALLs were less methylated than their disomic counterparts. Decreased methylation of gained chromosomes is a previously unknown phenomenon that may have ramifications not only for the pathogenesis of high hyperdiploid ALL but also for other disorders with acquired or constitutional numerical chromosome anomalies.
INTRODUCTION
The two most common genetic subgroups of pediatric B-cell precursor acute lymphoblastic leukemia (ALL) are the ones represented by t(12;21)(p13;q22), leading to the EVT6/RUNX1 fusion, or high hyperdiploidy [51-67 chromosomes], characterized by tri-/tetrasomies involving mainly chromosomes X, 4, 6, 8, 10, 14, 17, 18 and 21 (1) . Although these genetic aberrations most likely are of utmost importance for leukemogenesis, there is ample evidence that they are not sufficient for leukemic transformation (2) . The strongest support in favor of this has come from studies identifying ETV6/RUNX1 or high hyperdiploidy in neonatal blood spots from children who later developed ALL. Thus, these changes occur prenatally but secondary events are needed for overt disease. Regarding ETV6/RUNX1, frequent additional changes include losses of the EBF1, ETV6 and PAX5 genes and gains of chromosome 21 and chromosome arm Xq, whereas common additional aberrations in high hyperdiploid ALL include duplication 1q, deletions of CDKN2A and PAX5 and mutations of FLT3, NRAS, KRAS and PTPN11 (3) (4) (5) (6) (7) (8) . Many of the secondary changes are genomic imbalances, aberrations that generally have been shown to affect gene dosage and lead to aberrant expression patterns (9) . Gene dysregulation through epigenetic abnormalities may hence be an additional mechanism that also plays an important role. However, prior to the present study this has not been investigated in a detailed and genome-wide fashion in these common childhood ALL subtypes.
Hypermethylation of CpG islands situated within, or in close proximity of, promoters is an epigenetic modification frequently resulting in down-regulation or silencing of genes (10) . To date, most methylation studies have been performed on individual genes in malignant solid tumors (11) (Supplementary Material,  Table S1 ), and although several genes have been reported to be hypermethylated in B-lineage ALL (Supplementary Material, Tables S2 and S3) , such as CDKN2B and FHIT, nothing is known about the complete methylomes in this disorder. During recent years, several platforms assessing global CpG island methylation patterns have been developed (11) (12) (13) . Until now, however, these methods have mainly been used on cell lines (13) (14) (15) (16) (17) , and even though such analyses are important as a proof of principle, cell lines may have significantly altered methylomes due to in vitro culturing (15, 18) . As regards primary pediatric B-lineage ALL, most previous studies on aberrant methylation patterns have only focused on a few or even single genes (Supplementary Material, Table S3 ). In fact, we know of only two studies utilizing array-based methodologies to identify differential methylation of a larger number of genes in B-lineage ALL, one screening close to 60 genes (17) and one investigating 2300 genes (16) ; however, these studies included mainly adult patients. Thus, next to nothing is known about the DNA methylome of childhood ALL.
Herein, we investigated primary patient samples from the two most common genetic subgroups of pediatric ALL, namely ETV6/RUNX1 and high hyperdiploidy ( Table 1) . We analyzed large-scale global methylation profiles of each chromosome as well as direct gene silencing through hypermethylation by the use of a microarray platform comprising a total of 28 226 CpG islands in order to delineate the DNA methylome and to identify target genes for hypermethylation. In addition, gene expression data based on cDNA microarrays (19) were used to investigate correlations between hypermethylated target genes and their expression levels. Furthermore, tiling resolution array comparative genomic hybridization (array CGH) (20) was performed on each case to detect genomic imbalances that might affect gene expression and/or be associated with large-scale methylation changes.
RESULTS

Hypermethylated genes
A total of 8662 different genes with significant 5 0 promoter CpG island methylation scores were identified by the CpG promoter array, constituting 30% of all genes present on this platform. As seen in the flow chart in Figure 1 , the high hyperdiploid ALLs harbored more hypermethylated genes than the ETV6/RUNX1-positive cases (7650 versus 3983), with 2971 being common to the two groups. The hypermethylated genes were distributed on all chromosomes, without any clear association with chromosomes frequently gained in ETV6/RUNX1-positive or high hyperdiploid ALLs (Supplementary Material, Table S4 ). The 30 genes displaying the highest methylation scores among all the 8662 hypermethylated genes are listed in Supplementary Material, Table S5 and the top 30 scored genes in the two genetic subtypes are given in Supplementary Material, Table S6 which includes six genes common to both cytogenetic subgroups. Supplementary Material, Table S7 lists only the top genes uniquely hypermethylated in each ALL subtype. As seen in these tables, the largest gene ontology (GO) group was transcription regulation.
Segmentation analysis of the CpG peak score data of the 8662 genes (see above and Fig. 1 ) identified 138 genes High hyperdiploid þX,þ4,þ6,þ14,þ17,þ21
The original karyotypes of all cases and the array CGH data on cases 1 -10, 12 and 18 have previously been reported (5, 7, 8) . Fig. S1 ). These genes could be subgrouped into seven GO groups, with the most common being cell signaling, transcription regulation and apoptosis. Gene expression data, corresponding to log2 ratios for .50% of cases in each genetic subgroup, could be extracted for 75 of the 138 genes. It was apparent that enrichment for methylation not necessarily resulted in decreased expression. In fact, 11 of the 75 genes displayed a higher mean expression level in cases with methylation peaks than in those without such peaks, whereas 19 did not differ substantially between methylated and non-methylated cases (Supplementary Material, Table S8 ). However, the majority (45 genes; 60%) showed a peak associated with a significant decrease in expression ( Table 2 ).
A total of 117 genes displayed peaks in !30% of cases in each genetic subgroup, and among the 236 different genes listed in Supplementary Material, Tables S1, S2 and S9 -S11, 97 displayed CpG island peaks, 47 of which were also included among the 117 methylated genes identified earlier.
Thus, a total of 167 different recurring genes and/or genes involved in B-cell development or mutated or rearranged in B-lineage ALL were found to be targets for hypermethylation. Only 18 of these were among the 138 genes found by the segmentation analysis (see above and Fig. 1 ). The 167 genes could be subgrouped into nine specific GO groups, with the most common being transcription regulation, apoptosis and cell signaling (Supplementary Material, Fig. S2 ). Gene expression data could be extracted for 107 of the 167 genes. Thirteen of the 107 genes displayed a higher mean expression Table S12 ). The remaining 36 (34%) genes showed a methylation peak associated with a significant decrease in expression ( Table 3 ). The genomic positions of the methylation peaks, the peak sizes, the probe densities and the positions of the peaks in relation to the transcription start sites of all genes listed in Tables 2 and 3 are given in Supplementary Material, Table S13 .
DNA methylation hotspots throughout the genome
A total of 58 different regions/hotspots with a peak score density higher than four hypermethylated genes per 4 Mb was identified, with 30 of these being common to both ETV6/RUNX1-positive and high hyperdiploid ALLs. The ETV6/RUNX1-positive ALLs harbored eight unique methylation hotspots, whereas the high hyperdiploid ALLs had 20 unique methylation hotspots (Fig. 2, Supplementary Material,  Fig. S3 ).
Clustering analysis of chromosome-wide methylomes and gene expression data hyperdiploid cases (Fig. 3 ), indicating that they, to a large extent, are characterized by different chromosome-wide methylation patterns and expression profiles. In agreement with previous findings (13), gene rich BAC clones tended to be more methylated than those harboring no or only a few genes ( However, it is important to stress that a high methylation level of a BAC clone not necessarily was associated with CpG hypermethylation of individual genes. In fact, a large proportion of the 71 different genes that had methylation peaks and that were underexpressed (Tables 2 and 3) did not map to hypermethylated BAC clones (data not shown).
Comparison of chromosome-wide methylomes in ETV6/ RUNX1-positive and high hyperdiploid ALL When comparing the mean methylation levels in the two ALL types, differences between the high hyperdiploid and the ETV6/RUNX1-positive ALL as regards chromosome-wide methylation patterns on chromosomes 6, 10, 14, 16, 17, 18, 19 and 21 are clearly seen, with the former cases generally displaying a lower methylation of these chromosomes (Fig. 4 , Supplementary Material, Fig. S4 ). It is noteworthy that the majority of these chromosomes are the ones that are most commonly gained in ALL with high hyperdiploidy (1). Fig. S5 ). Thus, gains in high hyperdiploid cases were strongly associated with decreased methylation of the additional chromosomes. The same phenomenon was not seen in ETV6/RUNX1-positive ALL. Among the 10 cases analyzed, 16 had either trisomy 21 or gain of a large part of that chromosome (Table 1) . However, there were no methylation differences between those with or without such gains (Supplementary Material, Fig. S5 ).
Gene expression profiling of disomic and trisomic/tetrasomic chromosomes
Lowess curves of mean-centered expression ratios of disomies, trisomies and tetrasomies for all chromosomes within the high hyperdiploid subgroup and between high hyperdiploid cases and all other pediatric B-lineage ALL analyzed in the study by Andersson et al. (19) were compared. We observed global overexpression of genes on the additional chromosomes in the high hyperdiploid cases, when compared with other ALL subtypes as well as when comparing disomic and trisomic/tetrasomic chromosomes within the high hyperdiploid group (Supplementary Material, Fig. S6 ).
Bisulfite sequencing
In the validation assay of the promoter CpG island methylation profiling, the array results corresponded to the bisulfite sequencing results of the seven selected genes (BAD, BBC3, CAV1, CDK2AP1, NPM1, PRKCDBP and THEM4) in all cases, i.e. low or moderate methylation was found when the investigated regions were situated outside the peak and hypermethylation was detected when the analyzed segments were situated within the peak region (Supplementary Material, Fig. S7 ).
DISCUSSION
During recent years, our knowledge about the global patterns of genomic alterations in childhood ALL has expanded dramatically (4, 7, 8) . In contrast, no studies have focused on the genome-wide epigenetics of pediatric ALL; this is surprising considering that CpG hypermethylation of tumor suppressor genes has been demonstrated to be frequent in various neoplastic disorders (10) . For this reason, we performed an in-depth analysis of global DNA methylation changes in the two most common genetic types of pediatric hematologic malignancies, including only primary patient material in order to avoid methylation artifacts arising from in vitro culturing.
It is noteworthy that none of the 30 genes displaying the highest methylation peak scores in the two genetic subgroups (Supplementary Material, Tables S5-S7) have previously been implicated as hypermethylated in neoplasia (Supplementary Material, Tables S1 and S2), a finding that emphasizes the value of performing genome-wide methylation analyses to identify novel hypermethylated candidate genes. As seen in Supplementary Material, Tables S5 -S7, transcription regulation factors were particularly frequent among the genes with the highest methylation scores. Most likely, some of these genes, in particular those common to both subtypes (Supplementary Material, Table S6 ), may represent genes that are physiologically hypermethylated in early B-cell precursors and that hence may be associated with normal B-cell development. On the other hand, the genes that were differentially hypermethylated in the two different genetic subgroups (Supplementary Material, Table S7 ) are probably of leukemogenic importance.
Interestingly, among the genes with significant promoter methylation (Supplementary Material, Figs S1 and S2), only 30-60% were shown to be underexpressed (Tables 2 and 3 ). This clearly shows that hypermethylation per se does not necessarily lead to decreased gene expression. This has previously been demonstrated in high hyperdiploid ALL for the FHIT gene, which displayed no differential expression between methylation-positive and -negative cases (21) . In fact, among the 16 hypermethylated genes identified in the study by Paulsson et al. (21) , six were also found in the present study, namely CD44, CDH13, FHIT, PAX6, RARB and WT1, and expression data were available for five of these, showing downregulation of CD44 and CDH13, no differential expression for FHIT and RARB, and upregulation of WT1, again emphasizing that other factors besides CpG island methylation influence gene expression patterns. As regards the hypermethylated and underexpressed genes (Tables 2 and 3) , the three most common GO groups were (i) transcription regulation, with BRDT, HLF, SOX30 and SSX4 being hypermethylated in the majority of cases, (ii) apoptosis, with BBC3 and FOXO3A frequently being hypermethylated in both high hyperdiploid and ETV6/RUNX1-positive ALLs and (iii) cell signaling, with frequent hypermethylation of the CSF2RA, GALNAC4S-6ST and PTPN3 genes (Supplementary Material, Figs S1 and S2). These genes could hence be potentially important targets and markers for future treatment trials with demethylating agents. It has previously been demonstrated that simultaneous occurrence of hypermethylation and deletion causing biallelic gene inactivation is a rare event (22) . Our findings agree well with this since none of the deletions identified by the array CGH analysis (Table 1) were associated with hypermethylated BAC clones or promoters in the retained chromosomal regions (Fig. 5 and data not shown) . Cooperation between methylation events and copy number alterations is therefore unlikely to play a pathogenetically significant role in pediatric ALL.
The present genome-wide promoter methylation analysis identified a total of 58 different methylation hotspots, with eight and 20 being unique for the ETV6/RUNX1-positive and high hyperdiploid ALLs, respectively (Fig. 2, Supplementary  Material, Fig. S3 ). One large methylation hotspot common to both subtypes was located on chromosome arm 19q (Fig. 2) . Interestingly, this methylation hotspot has previously been reported in ALL and harbors several maternally imprinted genes (16) . This could suggest that the other methylation hotspots identified herein also include imprinted genes. To test this possibility we used the comprehensive mapping information provided by Luedi et al. (23) on all known, or putatively, imprinted human genes. We then ascertained the number of imprinted genes per chromosome band and evaluated how often bands with a specific number of imprinted genes harbored methylation hotspots. As seen in Figure 6 , there is a high correlation between the presence of imprinted genes and methylation hotspots, with the frequencies of methylation hotspots increasing with the number of imprinted genes. This strongly suggests that regions rich in imprinted genes are associated with methylation hotspots in ETV6/ RUNX1-positive and high hyperdiploid ALLs. One may hypothesize that imprinted genes are more susceptible to de novo methylation of the active allele and hence biallelic silencing.
The detection of subtype-specific methylation hotspots (Fig. 2) indicates that ETV6/RUNX1-positive and high hyperdiploid ALLs are characterized by different global methylation patterns. Further support for this was derived from the clustering analyses which successfully could subgroup the ETV6/ RUNX1-positive and high hyperdiploid cases (Fig. 3) . It has previously been reported that the profiles of CpG island hypermethylation of tumor suppressor genes differ between different tumor entities (10) and that acute myeloid leukemia and ALL can be separated using a 57 gene/249 CpG methylation array (17) . The present study is the first to use global methylation patterns to distinguish different genetic subtypes of ALL. Thus, genome-wide methylation analyses can be used to subdivide morphologically identical, but genetically and clinically distinct, hematologic malignancies, a finding that may have ramification also for other tumor types. An intriguing and unexpected finding was the clear-cut differences between the high hyperdiploid and the ETV6/ RUNX1-positive ALLs as regards the chromosome-wide methylation patterns, with the majority of the commonly gained chromosomes in the former subtype being less methylated than their disomic counterparts (Fig. 4, Supplementary  Material, Fig. S4 ). Since we did not observe the same phenomenon in the ETV6/RUNX1-positive ALL cases with or without trisomy 21 (Supplementary Material, Fig. S5 ) it is apparent that gains as such do not correlate with chromosome-wide differential methylation and that the methylation changes hence depend on other factors, for example chromosome type, number of gains and cell of origin. We know of only one previous study reporting similar findings, namely the one by Weber et al. (13) who identified an overall lowered methylation in gene-poor regions of trisomic chromosomes in a colon cancer cell line. However, we observed decreased methylation in primarily gene-poor regions only on chromosomes 6 and 8 in the high hyperdiploid ALLs. In contrast, this was not the case for chromosomes 4, 10, 14, 16, 18, 19 and 21; on these chromosomes the lowered methylation was equally distributed irrespective of the number of genes on the BAC clones (Supplementary Material, Figs S4 and S5) . The latter finding agrees well with previous data showing no clear bias for decreased methylation only of gene-poor regions in the inactive and hypomethylated X chromosome in females (24) .
It has previously been demonstrated that aneuploidy in yeast is associated with expression of the great majority of the genes on the extra chromosomes. However, even if the amount of transcript is increased, the protein levels are often not increased because of either non-translation or degradation (25) . Thus, the overexpression of genes on additional chromosomes in high hyperdiploid cases, when compared with other ALL subtypes (19) or when comparing disomic and trisomic chromosomes within the high hyperdiploid group (Supplementary Material, Fig. S6 ), does not by necessity translate into protein abundance. Hence, the role of the decreased methylation of the gained chromosomes could be unrelated to gene expression. Instead, the differential methylation may be necessary for proper compartmentalization of the tri-/tetrasomic chromosomes in interphase, akin to Barr body formation of the inactive X chromosome, which, surprisingly, has been shown to be globally hypomethylated relative to its active counterpart (13) .
Recently, it was shown that aneuploidy generally inhibits tumorigenesis in murine experimental systems, being associated with decreased proliferation; however, the opposite effect-oncogenesis-may occur with gains of certain specific chromosomes (26, 27 ). An abnormal chromosome number as such is hence unlikely to be sufficient to drive oncogenesisother genetic or epigenetic changes are needed in addition. The lowered methylation identified herein may be one such event, perhaps abrogating the reduced cellular fitness associated with aneuploidy, and may have ramifications not only for the pathogenesis of high hyperdiploid ALL but also for other disorders with numerical chromosome anomalies.
MATERIALS AND METHODS
Patients and samples
Samples from 20 children with B-cell precursor ALL, comprising 10 with high hyperdiploidy and 10 with the ETV6/ RUNX1 fusion, were included in the study (Table 1 ). All patients had been diagnosed and treated according to the NOPHO-ALL 1992 or 2000 protocols at the Departments of Pediatric Oncology and Hematology, Lund University Hospital, Lund, and Linköping University Hospital, Linköping, Sweden. The study was reviewed and approved by the regional research ethics boards at Lund and Linköping Universities, and informed consent was obtained from the patients' parents or guardians in accordance with the Declaration of Helsinki. DNA was extracted, at the time of diagnosis, from bone marrow samples in cases 1 -19 and from peripheral blood in case 20. All the samples were cytogenetically characterized by conventional chromosome banding analysis. The presence of the cytogenetically cryptic ETV6/RUNX1 fusion was ascertained by RT -PCR and verified by FISH using locus-specific probes for the ETV6 and RUNX1 genes. The additional chromosomes identified by G-banding in the high hyperdiploid cases were, in the present study, all confirmed by array CGH (see in what follows). DNA and RNA were extracted using standard methods, and the DNA was purified further with the DNeasy Blood & Tissue Kit (Qiagen, Solna, Sweden) and quantified using a Nanodrop Spectrophotometer (Nanodrop Technologies, Wilmington, DE).
Array comparative genomic hybridization
Array CGH slides, containing 32 433 tiling BAC clones covering at least 98% of the human genome, were produced at the SCIBLU DNA microarray resource center at Lund University, Sweden. Labeling of DNA, slide preparation and hybridization were performed as described previously (20) . Male genomic DNA (Promega, Madison, WI) was used as reference in all hybridizations.
Analyses of the microarray images were performed as described previously (8) . To identify imbalances the BASE (28), the CGH Explorer software (29) and the TM4 microarray software suite (30) were applied. Classification as gain or loss was based on the log2 ratios, where . +0.5 in five adjacent clones were classified as aberrant, with +0.5 -1.0 Figure 6 . Mapping information on all known, or putatively, imprinted human genes was retrieved from Luedi et al. (23) and compared with the location of methylation hotspots. As seen, there is a high correlation between the presence of imprinted genes and hotspots, with the frequencies of hotspots increasing significantly with the number of imprinted genes.
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interpreted as duplications/hemizygous deletions and .+1.0 as amplifications/homozygous deletions.
Methylated DNA immunoprecipitation
Six micrograms of DNA from each sample was diluted in deionized water, yielding a concentration of 75 ng/ml. The DNA was sonicated with a Sonifier set to 20% amplitude for 0.5 s in 60 cycles to generate fragments ranging from 200 to 1000 bp (verified by gel electrophoresis). The fragmented DNA was diluted to a concentration of 13.4 ng/ml and denatured for 10 min at 958C, after which an input fraction (250 ng), serving as a reference in subsequent microarray hybridizations, was collected and stored at 2808C. The remaining DNA was immunoprecipitated overnight with a monoclonal antibody against 5-methylcytidine (Diagenode, Liège, Belgium) in a total of 500 ml 1Â IP buffer at 48C, as previously described (13) . The mixture was then incubated with 80 ml of Protein A Agarose beads (Invitrogen, Carlsbad, CA) for 2 h at 48C and subsequently washed three times with 1Â IP buffer to remove DNA with no or low level methylation. The beads were then treated overnight with proteinase K at 558C. After centrifugation, methylated DNA in the supernatant was recovered using standard phenol-chloroform extraction and ethanol precipitation. Both the input fraction and the methylated DNA were then amplified using the WGA2 kit (Sigma-Aldrich, St. Louis, MO), generating sufficient amounts (6 mg) for the various microarray hybridizations, as detailed in what follows.
CpG island and promoter methylation profiling
Four micrograms of methylated and input fraction DNA were analyzed using the NimbleGen CpG Island-Plus-Promoter Array (Roche NimbleGen, Madison, WI) by the NimbleGen Service Group (Reykjavik, Iceland) who performed the quality control, labeling, hybridization and scanning. This array platform covers all 28 226 UCSC-annotated CpG islands and promoter regions for all RefSeq genes, including 385 000 probes of 50-75 mer length per array, with an upstream and downstream promoter tiling of 800 bp and 200 bp, respectively. Signal intensity data were extracted from the scanned images. Each feature on the array has a corresponding log2 ratio, which is the ratio of the input signals for the methylated DNA and the input fraction DNA. The log2 ratio was scaled in order to center the ratio data around zero by subtracting the bi-weight mean for the log2 ratio values for all features on the array from each log2 ratio value. A modified ACME algorithm (31) , where a fixed-length window (750 bp) is placed around each consecutive probe, and the one-sided Kolmogorov -Smirnov test were then applied on the scaled log2 ratio data to determine whether the probes were drawn from a significantly more positive distribution (peak) of intensity log2 ratios than the other probes in the array. The resulting score for each probe is the 2log10 P-value from the windowed Kolmogorov-Smirnov test around that probe.
Delineation of hypermethylated genes
Peak data were generated by searching for probes above a P-value minimum cut-off (2log10) of 2. Peaks within 500 bp of each other were merged. Each annotated gene was subsequently searched for peaks appearing in a specified promoter region around the transcription start site. The region searched was design-specific, spanning from 5 kb upstream to 1 kb downstream of the transcription start site. Genes that had at least two probes with peaks above the P-value minimum cut-off were considered to have significant CpG island methylation scores for hypermethylation. In this fashion only 5 0 promoter CpG islands were investigated. The detected hypermethylated genes were analyzed in three different ways.
First, all genes with significant CpG island methylation scores were grouped according to ALL subtype in order to identify those that were uniquely hypermethylated in either ETV6/ RUNX1-positive or high hyperdiploid cases. Furthermore, the chromosomal distribution of all genes was ascertained.
Second, an edge preserving smoother analysis (29) , determining a sequence with as few jumps as possible, was performed. We used the Potts filter with the penalty parameter set to 2 and limited the least allowed aberration size to two clones. This segmentation analysis of the peak score data was performed in order to identify peaked genes throughout the genome that were highly enriched for methylation.
Third, we identified all genes that displayed methylation peaks in !30% of cases in either genetic ALL subgroup or that were present in Supplementary Material, Tables S1, S2 or S9 -S11, which comprise genes known to be hypermethylated in malignant disorders, involved in B-cell development or mutated or rearranged in B-lineage ALL. Each gene was then functionally annotated using the EASE software (32) and correlated with gene expression data.
Identification of DNA methylation hotspots
Identification of regions with a dense occurrence of hypermethylated genes, i.e. genomic sites harboring a significantly higher number of peak-scored probes compared with the rest of the genome, was performed by plotting the spatial and number distribution of peak scored promoters using an Epanechenikov kernel density estimator in CGH Explorer (29) . The size determinant was set to 4 Mb. In order to designate a chromosomal segment as a methylation hotspot at least four peak-scored probes had to be present within the 4 Mb segment analyzed.
Chromosome-wide methylation profiling
Of the methylated and input fraction DNA, 1.5 mg was differentially labeled with Cy3 and Cy5, respectively, and hybridized to 32K BAC array slides. Labeling of DNA, slide preparation, hybridization and analysis were performed as described previously (8, 20) . Classification as relative enrichment for methylation was based on the log2 ratio for each of the 32 433 BAC clones smoothed with the factor of 0.33, with a positive ratio indicating enrichment of methylation.
Unsupervised clustering analysis, after using a variance filter with a cut-off value of 0.25 standard deviation to limit the number of probes and a Pearson uncentered test (30) for average linkage clustering, was used to investigate methylation differences/similarities between the ETV6/RUNX1-positive and high hyperdiploid cases. In addition, a two
group comparison was performed using PCA in the Qlucore Software (Qlucore AB, Lund, Sweden). Average log2 ratios for each BAC clone of the ten high hyperdiploid and the ten ETV6/RUNX1-positive ALLs, respectively, were plotted towards the genomic position on each chromosome. The two groups were also analyzed in relation to the gene density on each clone by ascertaining, using a custom-made script, the number of annotated RefSeq genes on each consecutive clone. All clones on each chromosome were grouped in relation to the number of genes they harbored, generally ranging from 0 to 12 genes. The average log2 ratio for each such group was then plotted against their gene content.
Global gene expression analysis
RNA extraction, amplification, labeling, hybridization to 27K cDNA microarray slides, scanning, post-hybridization washing and feature analysis have previously been described (19, 33) . In short, the samples were hybridized to microarray slides containing 25 648 cDNA clones (SCIBLU DNA microarray resource center) and amplified RNA from the Universal Human Reference (Agilent Technologies, Palo Alto, CA) was used as reference. The data analyses were all performed using the BASE (28), TM4 (30) and Statistica (StatSoft Scandinavia AB, Uppsala, Sweden) software. The same type of clustering analysis that was performed on the chromosome-wide methylation profiles (discussed earlier) was used on the expression data.
Bisulfite sequencing
To validate the reliability of the promoter array, eight genes (BAD, BBC3, CAV1, CDK2AP1, NPM1, PRKCDBP, TES and THEM4) were selected from the identified 167 recurring target genes (Supplementary Material, Fig. S2 ; see Results). DNA (2 mg) from eight leukemic samples, comprising four ALL with high hyperdiploidy and four with ETV6/RUNX1, was treated with sodium bisulfite using the EpiTect kit (Qiagen, Valencia, CA). The bisulfite-treated DNA was used as a template in standard PCR amplification using primers directed towards the promoter regions harboring the hypermethylated CpG islands, as indicated by peaks in the array (primer sequences available upon request). The primers were designed using the MethPrimer software (34) . The PCR products were sub-cloned using the TOPO-TA system (Invitrogen, Carlsbad, CA) and sequenced using standard methods (MCLab, San Fransisco, CA). After sequencing 8 -12 clones per gene and case, one gene (TES) was excluded because it harbored too few informative CpG sites. The sequences were analyzed using the BiQ Analyzer software (35) . For a gene to be considered hypermethylated, the following criterion was used: at least 80% of the investigated clones should be methylated in at least 80% of the sequenced CpG sites.
Array data
The microarray data are deposited in the Array Express database (http://www.ebi.ac.uk/microarray.as/ae/).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
